NHS Announces Unexpected Increase in Savings from Switching to Biosimilars

Published date07 August 2018
Law FirmGoodwin
Subject MatterPrescription Drugs,Biosimilars,Generic Drugs,UK,Public Health,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT